313 related articles for article (PubMed ID: 25671623)
1. As Ebola epidemic begins to slow, trials of drugs and vaccines speed up.
Kuehn BM
JAMA; 2015 Mar; 313(10):1000-2. PubMed ID: 25671623
[No Abstract] [Full Text] [Related]
2. New rules needed to stop the Ebola epidemic.
Hasle G
Tidsskr Nor Laegeforen; 2014 Oct; 134(19):1826-7. PubMed ID: 25314981
[No Abstract] [Full Text] [Related]
3. Ethical allocation of drugs and vaccines in the West African ebola epidemic.
Gostin LO
Milbank Q; 2014 Dec; 92(4):662-6. PubMed ID: 25492601
[No Abstract] [Full Text] [Related]
4. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.
Cavaleri M; Thomson A; Salmonson T; Hemmings RJ
Clin Trials; 2016 Feb; 13(1):101-4. PubMed ID: 26768561
[No Abstract] [Full Text] [Related]
5. A US Food and Drug Administration perspective on evaluating medical products for Ebola.
Russek-Cohen E; Rubin D; Price D; Sun W; Cox E; Borio L
Clin Trials; 2016 Feb; 13(1):105-9. PubMed ID: 26768565
[No Abstract] [Full Text] [Related]
6. INFECTIOUS DISEASE. As Ebola epidemic draws to a close, a thin scientific harvest.
Cohen J; Enserink M
Science; 2016 Jan; 351(6268):12-3. PubMed ID: 26721981
[No Abstract] [Full Text] [Related]
7. Health plan.
Nature; 2015 Jun; 522(7554):5. PubMed ID: 26040857
[No Abstract] [Full Text] [Related]
8. Clinical trials of Ebola vaccine must continue despite fall in number of cases.
Gulland A
BMJ; 2015 Feb; 350():h944. PubMed ID: 25691506
[No Abstract] [Full Text] [Related]
9. [Overview of the Ebola vaccines in pre-clinical and clinical development].
Buchy P
Bull Soc Pathol Exot; 2016 Oct; 109(4):256-261. PubMed ID: 27646961
[TBL] [Abstract][Full Text] [Related]
10. The year that Ebola virus took over west Africa: missed opportunities for prevention.
Bausch DG
Am J Trop Med Hyg; 2015 Feb; 92(2):229-232. PubMed ID: 25561568
[No Abstract] [Full Text] [Related]
11. Statistics and logistics: Design of Ebola vaccine trials in West Africa.
Nason M
Clin Trials; 2016 Feb; 13(1):87-91. PubMed ID: 26768560
[No Abstract] [Full Text] [Related]
12. Ebola R&D woes spur action.
Check Hayden E
Nature; 2015 May; 521(7553):405-6. PubMed ID: 26017422
[No Abstract] [Full Text] [Related]
13. The Ebola Epidemic. High hopes for Guinean vaccine trial.
Enserink M
Science; 2015 Jan; 347(6219):219-20. PubMed ID: 25593164
[No Abstract] [Full Text] [Related]
14. WHO gives go ahead for experimental treatments to be used in Ebola outbreak.
Sayburn A
BMJ; 2014 Aug; 349():g5161. PubMed ID: 25122051
[No Abstract] [Full Text] [Related]
15. Drug and vaccine access in the Ebola epidemic: advising caution in compassionate use.
Hantel A; Olopade CO
Ann Intern Med; 2015 Jan; 162(2):141-2. PubMed ID: 25322080
[No Abstract] [Full Text] [Related]
16. The Ebola epidemic: a global health emergency.
Gostin LO; Lucey D; Phelan A
JAMA; 2014 Sep; 312(11):1095-6. PubMed ID: 25111044
[No Abstract] [Full Text] [Related]
17. Drug development for controlling Ebola epidemic - a race against time.
Gao J; Yin L
Drug Discov Ther; 2014 Oct; 8(5):229-31. PubMed ID: 25382559
[TBL] [Abstract][Full Text] [Related]
18. Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings.
Skrip LA; Galvani AP
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004802. PubMed ID: 27537602
[No Abstract] [Full Text] [Related]
19. [Ebola vaccine, therapeutics, and diagnostics].
Furuyama W; Takada A
Uirusu; 2016; 66(1):63-72. PubMed ID: 28484180
[TBL] [Abstract][Full Text] [Related]
20. Ebola treatments caught in limbo.
Reardon S
Nature; 2014 Jul; 511(7511):520. PubMed ID: 25079536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
